logo

Novavax Inc. (NVAX)



Trade NVAX now with
  Date
  Headline
6/11/2021 4:53:32 PM Novavax Announces Positive Data From Three Complementary Studies Of COVID-19 Beta Variant Strain Vaccine
5/10/2021 4:04:13 PM Novavax Reports Q1 Loss Per Share Of $3.05 Vs. $0.58 Last Year
5/10/2021 9:15:04 AM Novavax Says Data From Preclinical Study Of Combination Quadrivalent Seasonal Flu Vaccine And COVID-19 Vaccine Candidate
5/6/2021 9:06:49 AM Novavax And Gavi Execute Advance Purchase Deal For COVID-19 Vaccine For COVAX Facility
5/5/2021 5:17:12 PM Novavax: New England Journal Publishes Phase 2b Trial Results On Efficacy Of COVID-19 Vaccine Against B.1.351 Variant
5/3/2021 8:54:32 AM Novavax Begins Pediatric Expansion Of Its Phase 3 Clinical Trial For NVX-CoV2373
4/23/2021 5:06:30 AM Novavax Announces Pre-print Publication Of Data From Malaria Vaccine Phase 2b Clinical Trial Results In The Lancet
4/13/2021 5:51:34 PM Novavax CFO Greg Covino To Step Down
4/5/2021 4:06:39 PM Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover